from the world's big
Instantly translate your voice into 110+ languages from your device
Sheltering at home won't last forever. This translator is a traveler's best friend.
- LingvaNex Translator lets you speak to your Uber driver, B&B host, or waiter in almost any country with ease.
- The dictionary function helps you use foreign words in the right context.
- You can instantly translate text on image and websites.
We might be sheltering at home right now, but that won't last forever. Though you may be brushing up on your language skills during this time, the ability to talk to anyone in the world is a skillset beyond most humans.
That's where LingvaNex Translator comes in. This unique program lets you read, write, and speak in over 110 languages. This powerful translation and dictionary app offers instant translations of text, voice, images, websites, and documents. Right now, LingvaNex Translator: Lifetime Subscription (Desktop and Mobile Bundle) is on sale for 80% off, just $79.99.
That means you'll never have to flip through a book you picked up at the airport or scroll through local search apps hoping to find the right words. In fact, the dictionary even helps you nail the context.
You don't even need to travel to use LingvaNex Translator. Discover what's happening overseas from local news sources, and even translate text on images. You can save your favorite translations in the bookmarks and revisit them to help grow your vocabulary over time.
Lingvanex Translator is available on mobile or desktop for iOS, Android, macOS, and Windows users. Apple users rate it 4/5 stars on the Mac App Store, while Google Play and Microsoft Store users both give it 4.4/5 stars.
Purchase LingvaNex Translator: Lifetime Subscription (Desktop and Mobile Bundle) today for just $79.99 and save 80% off the list price.
Price subject to change.
When you buy something through a link in this article or from our shop, Big Think earns a small commission. Thank you for supporting our team's work.
More from the Big Think Shop
- Work-from-home accessories to keep you productive
- DIY projects to keep you entertained indoors
- New skills you can learn without leaving home
Innovation in manufacturing has crawled since the 1950s. That's about to speed up.
Preliminary studies on mice show positive results.
- While the exact cause of Alzheimer's remains unknown, researchers are targeting toxic beta-amyloid buildup.
- A recent study on mice found oxytocin could be a protective agent against plaque buildup.
- Though more research needs to be conducted, this is a hopeful sign in our fight against a crippling disease.
Photo: Varlamova Lydmila / Shutterstock<p>As Eleftheria Kodosaki, an academic associate in Biomedical Sciences at Cardiff Metropolitan University, <a href="https://theconversation.com/could-love-hormone-oxytocin-help-treat-alzheimers-disease-heres-what-researchers-currently-know-143301" target="_blank">writes</a>, male mice were recently treated with the toxic beta-amyloid, resulting in the desired effect: their brain's synaptic plasticity suffered. The researchers then treated mice with the toxic beta-amyloid <em>and</em> oxytocin, which did not affect their neural plasticity. The team speculates that oxytocin may play a role in staving off memory loss.</p><p>That <em>might</em> is key. Kodosaki notes that this disease remains baffling. </p><p style="margin-left: 20px;">"In theory, being able to stop groups of toxic beta-amyloid from forming could potentially prevent memory loss and cognitive decline. Unfortunately, Alzheimer's disease is way more complicated than just an accumulation of beta-amyloid in the brain."</p><p>Plaque buildups have been discovered in people that don't have the disease or suffer from any symptoms. The beta-amyloid angle is only a theory, and there are others: as mentioned, genetics, as well as the <a href="https://linkinghub.elsevier.com/retrieve/pii/S0166223600020312" target="_blank">Tau hypothesis</a>. In 2002, researchers at the Institute of Psychiatry in De Crespigny Park, London speculated that tau proteins form neurofibrillary tangle inside of nerve cell bodies, resulting in the collapse of neuronal transport systems. </p><p>Kodaski points out that all medication targeting beta-amyloid has failed. She also notes that research needs to be conducted on female mice, as women are more likely to develop Alzheimer's than man. Of course, humans are not mice, though taking note of sex differences in mice might help researchers gauge potential therapies in humans. </p><p>As most studies conclude, more research is needed. But it is a hopeful sign for treating the frustrating realm of dementia. In an aging world with a <a href="https://bigthink.com/politics-current-affairs/world-population-decline" target="_self">declining population</a>, we need to protect our seniors the best we can. </p><p>--</p><p><em>Stay in touch with Derek on <a href="http://www.twitter.com/derekberes" target="_blank">Twitter</a>, <a href="https://www.facebook.com/DerekBeresdotcom" target="_blank">Facebook</a> and <a href="https://derekberes.substack.com/" target="_blank">Substack</a>. His next book is</em> "<em>Hero's Dose: The Case For Psychedelics in Ritual and Therapy."</em></p>
Join Pulitzer Prize-winning reporter and best-selling author Charles Duhigg as he interviews Victoria Montgomery Brown, co-founder and CEO of Big Think.
Women today are founding more businesses than ever. In 2018, they made up 40% of new entrepreneurs, yet in that same year, they received just 2.2% of all venture capital investment. The playing field is off-balance. So what can women do?
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.